Jim Cramer says CVS stock is a buy at these levels. Here’s why
Jim Cramer from CNBC told investors why he was optimistic on Monday CVSEven if the health sector is delayed this year as a whole.
“[It’s] To correct the most problematic work, to see the real power in other parts of the work, especially on the pharmacy side, “he said.
Cramer, drug producers Trump administration, especially vaccine-septic Robert F. Kennedy Jr.’ın health and human services department leadership in the last months, while struggling in the last months, said biofarmasömasön. Companies are also worried about the effect of tariffs on drugs. Managed health names also face problems because they have to pay more than expected.
However, according to Cramer, CVS has become a “storm in the storm” for health investors, and stocks are currently increasing by more than 58% annually.
Cramer was influenced by the last quarter of the CVS, and the results have been a sharp change since last year, when the management cut the full year forecast several times. In July, retail pharmacy chain earnings and revenue estimates easily undertaken and increased the management appearance.
He suggested that the CVS managed care work is important to develop Eetna, a painful place. For Cramer, the work doesn’t develop exactly, but much better. While the company acknowledges that medical costs remain high, it was encouraged that CVS seems to be “finally taking its arms around the problem”.
Some of the success of the CVS owe the fall of the major competitors that allow the pharmacy business to get the market share “like crazy”. The company’s best competitor, WalgreensEarlier this year, he announced his plans to go private and close hundreds of stores in the process. The rival Rite AID recently applied for the second bankruptcy in two years.
Cramer, even if it is one of the lowest levels of last year, said he thought the stock was cheap.
“Although the stock is significantly recovered from these levels, now the rise of numbers is still super cheap.” He said.
CVS pointed out CNBC to CEO David Joyner’s comments last month from the earnings announcement.
“Our strong performance, an important and durable recovery in EETNA, a strong and lasting recovery in CVS Caremark, and a focus on the operational and financial improvement in our businesses under the leadership of CVS Pharmacy,” He said.
